SONNET BIOTHERAPEUTICS
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action. The company 's proprietary FHAB™ (Fully Human Albumin Binding) technology enables the development of innovative targeted biologic drugs with enhanced single- or bi-specific mechanisms. The FHAB™ platform utilizes a fully human single-chain antibody fragment (scFv) that binds to and “hitch-hikes” on human serum albumin (HSA) for transport to target tissues. Son... net’s FHAB construct attaches to albumin in the bloodstream, which significantly enhances the pharmacokinetics of the active drug substance. It also naturally accumulates at inflammation sites, including tumors, thereby potentiating delivery to target tissues. The Sonnet platform is differentiated in that FHAB utilizes a fully human sequence, with a human glycosylation profile that can be manufactured using a standard CHO process.
SONNET BIOTHERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2011-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.sonnetbio.com
Total Employee:
1+
Status:
Active
Contact:
609-375-2227
Total Funding:
30.75 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Universal Analytics Domain Not Resolving
Current Employees Featured
Susan Dexter Chief Technical Officer @ Sonnet BioTherapeutics
Chief Technical Officer
Dorr Andrew Chief Medical Officer @ Sonnet BioTherapeutics
Chief Medical Officer
John K. Cini Co-Founder and Chief Scientific Officer @ Sonnet BioTherapeutics
Co-Founder and Chief Scientific Officer
Pankaj Mohan Co-Founder, CEO & Chairman @ Sonnet BioTherapeutics
Co-Founder, CEO & Chairman
Jay Cross CFO @ Sonnet BioTherapeutics
CFO
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-04-01 | Chanticleer Holdings | Chanticleer Holdings acquired by Sonnet BioTherapeutics | N/A |
Official Site Inspections
http://www.sonnetbio.com Semrush global rank: 4.7 M Semrush visits lastest month: 2.05 K
- Host name: ec2-174-129-30-187.compute-1.amazonaws.com
- IP address: 174.129.30.187
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Sonnet BioTherapeutics"
About :: Sonnet BioTherapeutics, Inc. (SONN)
About Sonnet BioTherapeutics. Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action.See details»
Sonnet BioTherapeutics, Inc. (SONN)
The Sonnet F H AB Mechanism of Action. Our modular F H AB construct utilizes a validated, targeted albumin-binding approach to deliver cytokine payloads with enhanced penetration, …See details»
Management Team :: Sonnet BioTherapeutics, Inc.
Dr. Stephen J. McAndrew joined Sonnet BioTherapeutics in February, 2020 and currently serves as Chief Business Officer. Prior to joining Sonnet, from March 2014 to October 2019, Dr. McAndrew served as the Senior Vice President of …See details»
Sonnet BioTherapeutics - Crunchbase Company Profile …
Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action. The company 's proprietary …See details»
Sonnet BioTherapeutics - LinkedIn
Sonnet BioTherapeutics | 1,890 followers on LinkedIn. Powering a new wave of immune therapeutics | As experts in cytokine biology, our clinical stage pipeline comprises five cytokine-derived ...See details»
SONN - Sonnet BioTherapeutics Holdings, Inc. | Company Profile
Feb 28, 2025 www.sonnetbio.com. 609-375-2227. info@sonnetbio.com. Business Description. Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology …See details»
Sonnet BioTherapeutics Holdings (SONN) Company Profile
5 days ago Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human …See details»
Sonnet BioTherapeutics Holdings, Inc. (SONN) - Yahoo Finance
See the company profile for Sonnet BioTherapeutics Holdings, Inc. (SONN) including business summary, industry/sector information, number of employees, business summary, corporate …See details»
Sonnet BioTherapeutics
Feb 18, 2025 Sonnet BioTherapeutics was founded in 2016 by Dr. Rajan Sankaran and a team of researchers from Stanford University. Since its inception, the company has focused on …See details»
Sonnet BioTherapeutics, Inc. - SignalHire
Organization Website: sonnetbio.com : Social Links: Phone Number: 609-375-2227: Sonnet BioTherapeuti... industries Biotech, Pharmaceuticals: Headquarters Location: 100 Overlook …See details»
Sonnet BioTherapeutics - Craft
Oct 29, 2024 Sonnet BioTherapeutics has 5 employees at their 1 location and $18.63 k in annual revenue in FY 2024. See insights on Sonnet BioTherapeutics including office locations, …See details»
Sonnet BioTherapeutics - PitchBook
Sonnet BioTherapeutics General Information Description. Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its …See details»
Sonnet BioTherapeutics - VentureRadar
Website: http://sonnetbio.com/ Founded in 2011, Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for innovating ...See details»
Company Information :: Sonnet BioTherapeutics, Inc. (SONN)
Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action.See details»
Sonnet Biotherapeutics Holdings Inc (SONN-Q) Profile
See the company profile for Sonnet Biotherapeutics Holdings Inc (SONN-Q) including business summary, industry/sector information, business summary, corporate governance, key executives.See details»
Investor Relations :: Sonnet BioTherapeutics, Inc. (SONN)
Feb 26, 2025 Sonnet BioTherapeutics is an oncology-focused biotechnology company with a proprietary platform for developing targeted biologic drugs with single or bifunctional action. …See details»
Sonnet BioTherapeutics - Overview, News & Similar companies
Feb 7, 2023 Sonnet BioTherapeutics contact info: Phone number: (609) 375-2227 Website: www.sonnetbio.com What does Sonnet BioTherapeutics do? Founded in 2015, Sonnet …See details»
Sonnet BioTherapeutics Company Overview, Contact Details
Sonnetbio launches Abstract accepted for Presentation. Sonnet BioTherapeutics announces Abstract accepted for Presentation by a key opinion leader at the 2023 Connective Tissue …See details»
Board of Directors :: Sonnet BioTherapeutics, Inc. (SONN)
Nailesh Bhatt has served on Sonnet’s board of directors since July 2018, and was appointed to our Board at the closing of the Merger. Since January 2018, Mr. Bhatt has been the Chief …See details»
Sonnet BioTherapeutics Holdings, Inc. - Cruelty Free Investing
Company Website: https://www.sonnetbio.com Contact: info@sonnetbio.com ©2025 CrueltyFreeInvesting.org | Cruelty Free Investing is a registered 501c3 Non-Profit Organization …See details»